Pain Therapeutics, Inc.
| Nasdaq: PTIE
Pain Therapeutics, Inc. is a biopharmaceutical company, which develops novel drugs. It also engages in the developing pipeline of novel drug candidates in the area of oncology and hematology. The company developing a novel drug candidate to treat metastatic melanoma, a deadly form of skin cancer. It has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a novel radio-labeled monoclonal antibody to treat metastatic melanoma. The company was founded by Remi Barbier and in May 1998 and is headquartered in Austin, TX.